IWC
SRPT icon

Integrated Wealth Concepts’s Sarepta Therapeutics SRPT Stock Holding History

Integrated Wealth Concepts’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,735
Closed -$321K – 2526
2026
Q1 		$321K Sell
14,735
-852
-5% -$16.5K ﹤0.01% 1812
2025
Q4 		$335K Buy
+15,587
New +$328K ﹤0.01% 1274
2024
Q3 		– Sell
-1,294
Closed -$204K – 1732
2024
Q2 		$204K Buy
+1,294
New +$166K ﹤0.01% 1518

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Integrated Wealth Concepts's SRPT Position: Q2 2026 in Review

Integrated Wealth Concepts sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 14,735 shares — an estimated $321K sold.

Integrated Wealth Concepts first reported a position in SRPT in Q2 2024 and held it in 3 quarters. The position peaked at $335K in Q4 2025. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Integrated Wealth Concepts reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Integrated Wealth Concepts sold 14,735 Sarepta Therapeutics shares in Q2 2026, an estimated $321K.
  • Integrated Wealth Concepts first reported a position in Sarepta Therapeutics in Q2 2024 and held it in 3 quarters.
  • Integrated Wealth Concepts's Sarepta Therapeutics position peaked at $335K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.